Novartis Gene Therapy Treatment Might Cost Much Lower than $5 million to $4 Million
Publikováno: 23.5.2019
Swiss drug manufacturing behemoth Novartis has almost always been at the cutting edge of drug research and one of the most ambitious projects that the company had embarked on in recent years was the one related to gene therapy. Gene therapy is needed to treat spinal muscular atrophy and consists of a onetime treatment. However, …
The post Novartis Gene Therapy Treatment Might Cost Much Lower than $5 million to $4 Million appeared first on CryptoNewsZ.